Spots Global Cancer Trial Database for Study Evaluating the Ketogenic Diet in Patients With Metastatic Pancreatic Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study Evaluating the Ketogenic Diet in Patients With Metastatic Pancreatic Cancer
Official Title: Randomized Phase II Trial of Two Different Nutritional Approaches for Patients Receiving Treatment for Their Advanced Pancreatic Cancer
Study ID: NCT04631445
Interventions
Study Description
Brief Summary: This study will evaluate the effects of the ketogenic diet in patients with metastatic pancreatic cancer while receiving chemotherapy.
Detailed Description: A randomized, phase II trial designed to evaluate the progression free survival in patients with metastatic pancreatic cancer on triplet therapy (nab-paclitaxel + gemcitabine + cisplatin) while on ketogenic diet or non-ketogenic diet. This study also aims to compare the changes in serum metabolites and quality of life between the two arms.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Honor Health, Scottsdale, Arizona, United States
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
Nuvance Health-Danbury Hospital, Danbury, Connecticut, United States
Nuvance Health, Norwalk, Connecticut, United States
Tennessee Oncology, Nashville, Tennessee, United States
South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas, United States
Contact Details
Name: Vicki L Bauernschub, BSN RN
Affiliation: Translational Drug Development
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
